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Background: Distal myopathy with rimmed vacuoles/hereditary inclusion body myopathy is clinically characterized
by the early involvement of distal leg muscles. The striking pathological features of the myopathy are muscle fibers
with rimmed vacuoles. To date, the role of aquaporin-4 water channel in distal myopathy with rimmed vacuoles/
hereditary inclusion body myopathy has not been studied.
Case presentation: Here, we studied the expression of aquaporin-4 in muscle fibers of a patient with distal
myopathy with rimmed vacuoles/hereditary inclusion body myopathy. Immunohistochemical and
immunofluorescence analyses showed that sarcolemmal aquaporin-4 immunoreactivity was reduced in many
muscle fibers of the patient. However, the intensity of aquaporin-4 staining was markedly increased at rimmed
vacuoles or its surrounding areas and in some muscle fibers. The fast-twitch type 2 fibers were predominantly
involved with the strong aquaporin-4-positive rimmed vacuoles and TAR-DNA-binding protein-43 aggregations.
Rimmed vacuoles with strong aquaporin-4 expression seen in the distal myopathy with rimmed vacuoles/hereditary
inclusion body myopathy patient were not found in control muscles without evidence of neuromuscular disorders
and the other disease-controls.
Conclusions: Aquaporin-4 might be crucial in determining the survival or degeneration of fast-twitch type 2 fibers
in distal myopathy with rimmed vacuoles/hereditary inclusion body myopathy.
Keywords: Distal myopathy with rimmed vacuoles (DMRV)/hereditary inclusion body myopathy (hIBM), Rimmed
vacuoles (RVs), Aquaporin-4 (AQP4), Fast-twitch type 2 fiberBackground
Autosomal recessive distal myopathy with rimmed
vacuoles (DMRV)/hereditary inclusion body myopathy
(hIBM) is clinically characterized by preferential involve-
ment of the distal leg muscles in the very early stage, and
later of most proximal muscles. One of the striking patho-
logical features of this myopathy is muscle fibers with
rimmed vacuoles (RVs) [1,2]. DMRV/hIBM is caused by
a mutation in the uridine diphosphate-N-acetylglucosa-
mine 2-epimerase/N-acetylmannosamine kinase (GNE)
gene, which encodes a bifunctional enzyme catalyzing
the 2 exclusive rate-limiting reactions of sialic acid syn-
thesis in the cytosol [3,4]. However, why these mutations
produce a myopathy with RVs remains to be determined.* Correspondence: hoshia@fmu.ac.jp
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reproduction in any medium, provided the orAquaporin-4 (AQP4) is the main water channel of the
neuromuscular system. In the skeletal muscle, AQP4 is
predominantly localized to the sarcolemma of fast-twitch
type 2 fibers [5-7]. AQP4 expression in the muscles is
markedly reduced in patients with dystrophinopathy,
dysferlinopathy, and amyotrophic lateral sclerosis (ALS)
[8-10], but the pathophysiology underlying the reduction
in expression is unclear. Changes in AQP4 expression,
however, have not been studied in DMRV/hIBM thus far.
In this communication, we aimed to characterize AQP4
expressions in the muscle fibers of a patient with DMRV/
hIBM associated with GNE mutation. Furthermore, we
investigated accumulation of TAR-DNA-binding protein-43
(TDP-43), a pathological hallmark of vacuolar myopathies
[11,12], in the muscle fibers of DMRV/hIBM patients.Case presentation
A 20-year-old man was admitted to our hospital with gait
disturbance. He had no family history of neuromusculartd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Neurological examination showed marked weakness and
atrophy in the distal leg muscles and moderate atrophy in
the proximal leg muscles. Cranial muscles were not
involved and sensory examination was unremarkable.
No deformity of the spine and feet was noted. Serum
creatine kinase level was 599 IU/L (normal, 62–287 IU/L)
with no other routine biochemical abnormalities including
renal, liver, and thyroid functions and a battery of im-
munological markers (antinuclear antibody, rheumatoid
factor, anti-DNA antibody, Jo-1, etc) were all negative.
Electromyography showed myogenic changes with some
neurogenic changes in all muscles tested. Nerve conduc-
tion studies were unremarkable. Muscle magnetic reson-
ance imaging studies showed atrophies and degenerations
in the muscles of both anterior and posterior compart-
ments of the legs (Figure 1A). The hamstrings were mark-
edly involved muscles while the vastus lateralis, vastus
intermedius, and vastus medius were moderately involved
muscles (Figure 1B). Mutational analysis of GNE revealed
a homozygous 1714 G>C mutation.
Muscle biopsy samples were taken from the left quad-
riceps femoris, and the tissue specimens were immedi-
ately frozen in isopentane chilled with liquid nitrogen.
Serial 10-μm-thick transverse sections cut using a cryostat
were stained by routine muscle histochemical methods.
In addition, we performed immunohistochemical and
immunofluorescence studies (Additional file 1 shows
these methods in more detail).
Cryostat sections stained with hematoxylin and eosin
showed an increased variation in muscle fiber sizes,Figure 1 Muscle magnetic resonance imaging. T2-weighted
magnetic resonance images of the legs (A) and thigh (B) show severe
muscle atrophy and increased signal intensities in the tibialis anterior and
posterior, adductor longus and magnus, and biceps femoris muscles.angular atrophic fibers, central nuclei, and RVs with no in-
flammatory cell infiltrates (Figure 2A). The RVs and areas
surrounding the RVs showed intense AQP4 immunor-
eactivity, but the centers of the vacuoles were devoid of
immunoreactivity (Figure 2B, inset), while many muscle
fibers showed weak sarcolemmal AQP4 immunoreactiv-
ity (Figure 2C). Immunofluorescence analysis of AQP4
also showed that the RVs and the areas surrounding the
RVs were often strongly AQP4 positive (Figure 2D).
Further, strong cytoplasmic or cytosolic punctate AQP4
expression was occasionally observed (Figure 2D, inset).
Negative controls, which were not incubated with anti-
AQP4 antibody, showed no immunoreactivity (Figure 2E).
In a control muscle sample without evidence of neuro-
muscular disorders, AQP4 immunostaining clearly showed
the mosaicism in the AQP4 expression on the myofiber
surface (Figure 2F). RVs with intensive AQP4 expression
and sarcoplasmic AQP4 aggregates were never seen in the
control muscle. Moreover, double immunofluorescence
analysis of AQP4 and myosin heavy chain-fast (MHCF)
showed that AQP4was predominantly expressed in the
fast-twitch type 2 fibers (Figure 2G1-G3).
We next determined whether AQP4 expression was
associated with the type of fiber in the DMRV/hIBM
patient. RV-positive muscle fibers were predominantly
present in MHCF fibers, whereas only some were found
in myosin heavy chain-slow (MHCS) fibers in serial sec-
tions (Figure 3A-3C). Double immunofluorescence ana-
lysis of AQP4 and MHCF showed that RVs with strong
AQP4 expression were localized predominantly in the
MHCF fibers (Figure 3D1-D3). In addition, double immu-
nostaining of AQP4 and MHCS showed that RVs with
strong AQP4 expression were mostly located in the non-
MHCS fibers (Figure 3E1-E3). Furthermore, numerous
TDP-43 immunostained aggregates were detected in many
muscle fibers (Figure 3F). Double immunostaining of
TDP-43 and MHCF or MHCS revealed that the TDP-43
immunostaining was most commonly present in the
MHCF-positive fibers (Figure 3G), not in the MHCS fibers
(Figure 3H).
Subsequently, we performed a disease-control study of
muscle AQP4/dystrophin expression. RVs with intensive
AQP4 expression and sarcoplasmic AQP4 aggregates
frequently seen in the DMRV/hIBM patient were not
found in a female carrier of Duchenne muscular dystrophy
(DMD) or in an ALS patient (Figure 4). As expected,
both of the disease-controls showed some lack of AQP4/
dystrophin expression in the sarcolemma, as described
elsewhere [8-10].
Discussion
To the best of our knowledge, this is the first report
on AQP4 expression in the skeletal muscle of a DMRV/
hIBM patient. We showed that sarcolemmal AQP4
Figure 2 Pathology of muscle. Hematoxylin and eosin staining (A). Modified Gomori-trichrome staining (B) and immunohistochemical
examination of aquaporin-4 (AQP4) (inset) in the serial section (Note the arrow-heads). Immunohistochemical examination of AQP4 (C).
Immunofluorescence analysis of AQP4 shows that the rimmed vacuoles (RVs) and the areas surrounding the RVs are often strongly AQP4 positive
(D, arrow-heads) but not always so (D, arrow). Negative controls, without incubations with anti-AQP4 antibody (E). AQP4 expression in normal
control muscle (F). Double immunofluorescence analysis of AQP4 and myosin heavy chain-fast (MHCF) in the normal control muscle (G1-G3).
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DMRV/hIBM patient, a female carrier of DMD, and an
ALS patient. It is interesting to note that AQP4 staining
was markedly increased in the areas of the RVs and in some
muscle fibers in DMRV/hIBM. The most striking findings
were that the fast-twitch type 2 fibers were predominantly
involved with the strong AQP4-positive RVs and TDP-43
aggregations in DMRV/hIBM.
Our DMRV/hIBM case showed unusual involvement of
the quadriceps muscles. In general, even at the advanced
stage of DMRV/hIBM, quadriceps muscles are relatively
spared. However, an earlier study has described a DMRV/
hIBM patient with weakness of quadriceps [13]. Intri-
guingly, the study also reported that a non-DMRV/hIBM
patient with predominant proximal muscle weakness of
the lower extremities had GNE mutations [13]. On theother hand, quadriceps muscles of GNE knockout mouse
are preferentially involved [14]. It remains unknown why
clinical variations are observed in GNE-mutated DMRV/
hIBM. Further studies are needed to clarify the genotype/
phenotype correlations in DMRV/hIBM patients.
Our results about downregulation of AQP4 are consistent
with the results reported in other studies [8-10]. We sup-
pose that AQP4 downregulation occurs as a common path-
way in muscle degeneration at a late stage. An important
finding of our study is the result of AQP4-positive staining.
We show that AQP4 staining was markedly increased at
the RVs or the areas surrounding the RVs and in some
muscle fibers in our DMRV/hIBM patient. Furthermore,
fast-twitch type 2 fibers were predominantly involved with
the strong AQP4-positive RVs, while these findings were
not observed in a control muscle samples without evidence
Figure 3 Fast-twitch type 2 fibers are predominantly involved with strong aquaporin-4 (AQP4)-positive rimmed vacuoles (RVs) and
TAR-DNA-binding protein-43 (TDP-43) aggregation. Immunohistochemical examination of myosin heavy chain-fast (MHCF) and myosin heavy
chain-slow (MHCS) in serial sections (A-C, B is high-power view of A). Double immunofluorescence analysis of AQP4 and MHCF showed many RVs
with intense AQP4 expression in the MHCF-positive fibers (D1-D3, arrow-heads). Occasionally, the RVs with AQP4 expression were detected in the
MHCF-negative fibers (D1 and D3, arrows). Double immunostaining of AQP4 and MHCS showed that RVs with strong AQP4 expression were
mostly located in the non-MHCS fibers (E1-E3, arrow-heads). Immunohistochemical analysis of TDP-43 (F). Double immunostaining of TDP-43 and
MHCF revealed that the TDP-43 immunoreactivity is mostly present in MHCF fibers (G, arrows), not in the MHCS fibers (Fig. H).
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The lysosomal system is thought to be activated in DMRV/
hIBM muscle because of accumulation of various lysosome-
related proteins in the RVs [14,15]. Moreover, several
sarcolemmal proteins, α-dystroglycan, β-dystroglycan, andα-sarcoglycan are also accumulated in the myofibers of
the DMRV/hIBM mouse model, presumably because of
abnormal protein misfolding/aggregation [14,15]. We sur-
mise that the AQP4-positive aggregates in the sarcoplasm
and intense AQP4 expression with RVs are associated with
Figure 4 Double immunofluorescence analysis of aquaporin-4 (AQP4) and dystrophin in a female carrier of Duchenne muscular
dystrophy (DMD) and an amyotrophic lateral sclerosis patient (ALS). A female carrier of DMD showed a mosaic pattern of dystrophin-
positive and dystrophin-negative fibers on sarcoplasmic membrane with a markedly increased variability of muscle fiber diameters, and the
stainability of AQP4 was strikingly patchy; some large fibers showed positive staining for AQP4 whereas almost all the small fibers were negative
(A1-A3). The muscle specimens of an ALS patient showed that AQP4 immunoreactivity was weak or negative on the myofiber surface with group
atrophy, but dystrophin was clearly visualized on the denervated muscles (B1-B3).
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slow- to fast-twitch conversion of soleus fibers under
muscle unloading is associated with AQP4 expression in
rats [16]. The fact that the modulation of AQP4 expression
is associated with the transition of muscle fiber type indi-
cates that AQP4 is an important muscle protein involved
in muscle plasticity. In addition, AQP4 may protect against
muscle damage, by maintaining muscle volume regulation
and muscle osmolarity [6]. Thus, we consider that muscle
adaptation from type 1 to type 2 fibers is associated with
the change in AQP4 expression against muscle degener-
ation in DMRV/hIBM. A critical feature in terms of in-
volvement of a specific type of muscle fiber in DMRV/
hIBM is that the fast-twitch fibers are predominantly
affected [17]. As shown in our DMRV/hIBM patient, the
fast-twitch type 2 fibers would be more involved with
TDP-43 accumulation in the late stage. TDP-43 positive
aggregates have been observed in various vacuolar myop-
athies, which suggests that TDP-43 accumulation is more
likely to be a common endpoint of vacuolar muscle degen-
eration [11].
Conclusions
In conclusion, we found that many muscle fibers of a
patient with DMRV/hIBM showed a reduction of sarco-
lemmal AQP4 immunoreactivity, while fast-twitch type2 fibers were predominantly involved with strong AQP4-
positive RVs and TDP-43 aggregation. Although the func-
tional role of AQP4 in skeletal muscle is not well under-
stood, AQP4 might be crucial in determining the survival
or degeneration of fast-twitch type 2 fibers in DMRV/
hIBM.
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